TY - JOUR
T1 - Intestinal Metabolites Are Profoundly Altered in the Context of HLA–B27 Expression and Functionally Modulate Disease in a Rat Model of Spondyloarthritis
AU - Asquith, Mark
AU - Davin, Sean
AU - Stauffer, Patrick
AU - Michell, Claire
AU - Janowitz, Cathleen
AU - Lin, Phoebe
AU - Ensign-Lewis, Joe
AU - Kinchen, Jason M.
AU - Koop, Dennis R.
AU - Rosenbaum, James T.
N1 - Publisher Copyright:
© 2017, American College of Rheumatology
PY - 2017/10
Y1 - 2017/10
N2 - Objective: HLA–B27–associated spondyloarthritides are associated with an altered intestinal microbiota and bowel inflammation. We undertook this study to identify HLA–B27–dependent changes in both host and microbial metabolites in the HLA–B27/β2-microglobulin (β2m)–transgenic rat and to determine whether microbiota-derived metabolites could impact disease in this major model of spondyloarthritis. Methods: Cecal contents were collected from Fischer 344 33–3 HLA–B27/β2m–transgenic rats and wild-type controls at 6 weeks (before disease) and 16 weeks (with active bowel inflammation). Metabolomic profiling was performed by high-throughput gas and liquid chromatography–based mass spectrometry. HLA–B27/β2m–transgenic rats were treated with the microbial metabolites propionate or butyrate in drinking water for 10 weeks, and disease activity was subsequently assessed. Results: Our screen identified 582 metabolites, of which more than half were significantly altered by HLA–B27 expression at 16 weeks. Both microbial and host metabolites were altered, with multiple pathways affected, including those for amino acid, carbohydrate, xenobiotic, and medium-chain fatty acid metabolism. Differences were even observed at 6 weeks, with up-regulation of histidine, tyrosine, spermidine, N-acetylmuramate, and glycerate in HLA–B27/β2m–transgenic rats. Administration of the short-chain fatty acid propionate significantly attenuated HLA–B27–associated inflammatory disease, although this was not associated with increased FoxP3+ T cell induction or with altered expression of the immunomodulatory cytokines interleukin-10 (IL-10) or IL-33 or of the tight junction protein zonula occludens 1. HLA–B27 expression was also associated with altered host expression of messenger RNA for the microbial metabolite receptors free fatty acid receptor 2 (FFAR2), FFAR3, and niacin receptor 1. Conclusion: HLA–B27 expression profoundly impacts the intestinal metabolome, with changes evident in rats even at age 6 weeks. Critically, we demonstrate that a microbial metabolite, propionate, attenuates development of HLA–B27–associated inflammatory disease. These and other microbiota-derived bioactive mediators may provide novel treatment modalities in HLA–B27–associated spondyloarthritides.
AB - Objective: HLA–B27–associated spondyloarthritides are associated with an altered intestinal microbiota and bowel inflammation. We undertook this study to identify HLA–B27–dependent changes in both host and microbial metabolites in the HLA–B27/β2-microglobulin (β2m)–transgenic rat and to determine whether microbiota-derived metabolites could impact disease in this major model of spondyloarthritis. Methods: Cecal contents were collected from Fischer 344 33–3 HLA–B27/β2m–transgenic rats and wild-type controls at 6 weeks (before disease) and 16 weeks (with active bowel inflammation). Metabolomic profiling was performed by high-throughput gas and liquid chromatography–based mass spectrometry. HLA–B27/β2m–transgenic rats were treated with the microbial metabolites propionate or butyrate in drinking water for 10 weeks, and disease activity was subsequently assessed. Results: Our screen identified 582 metabolites, of which more than half were significantly altered by HLA–B27 expression at 16 weeks. Both microbial and host metabolites were altered, with multiple pathways affected, including those for amino acid, carbohydrate, xenobiotic, and medium-chain fatty acid metabolism. Differences were even observed at 6 weeks, with up-regulation of histidine, tyrosine, spermidine, N-acetylmuramate, and glycerate in HLA–B27/β2m–transgenic rats. Administration of the short-chain fatty acid propionate significantly attenuated HLA–B27–associated inflammatory disease, although this was not associated with increased FoxP3+ T cell induction or with altered expression of the immunomodulatory cytokines interleukin-10 (IL-10) or IL-33 or of the tight junction protein zonula occludens 1. HLA–B27 expression was also associated with altered host expression of messenger RNA for the microbial metabolite receptors free fatty acid receptor 2 (FFAR2), FFAR3, and niacin receptor 1. Conclusion: HLA–B27 expression profoundly impacts the intestinal metabolome, with changes evident in rats even at age 6 weeks. Critically, we demonstrate that a microbial metabolite, propionate, attenuates development of HLA–B27–associated inflammatory disease. These and other microbiota-derived bioactive mediators may provide novel treatment modalities in HLA–B27–associated spondyloarthritides.
UR - http://www.scopus.com/inward/record.url?scp=85031030061&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85031030061&partnerID=8YFLogxK
U2 - 10.1002/art.40183
DO - 10.1002/art.40183
M3 - Article
C2 - 28622455
AN - SCOPUS:85031030061
SN - 2326-5191
VL - 69
SP - 1984
EP - 1995
JO - Arthritis and Rheumatology
JF - Arthritis and Rheumatology
IS - 10
ER -